Related Experiment Videos
[Diabetic ketoacidosis during insulin pump therapy]
Deutsche Medizinische Wochenschrift (1946)
|May 5, 1989
Summary
Continuous subcutaneous insulin infusion (CSII) leaks can cause severe ketoacidosis in type-1 diabetics. Patients and doctors misdiagnosed gastrointestinal symptoms, emphasizing the need for patient education and frequent urine ketone testing.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Continuous subcutaneous insulin infusion (CSII) is a common treatment for type-1 diabetes.
- Effective CSII therapy requires proper patient training and system monitoring.
Observation:
- A system leak during CSII treatment in four type-1 diabetics led to severe ketoacidosis.
- Gastrointestinal symptoms like nausea, vomiting, and abdominal pain were observed.
- Mild hyperglycemia masked the severity of the condition, leading to misdiagnosis.
Findings:
- The CSII system malfunction was the primary cause of ketoacidosis.
- Misinterpretation of symptoms due to mild hyperglycemia delayed critical intervention.
- Patient and physician education on CSII complications is crucial.
Implications:
- Highlights the importance of comprehensive patient education and supervision during CSII initiation.
- Underscores the necessity for patients to perform frequent urine ketone body testing.
- Suggests improved diagnostic criteria for CSII-related complications are needed.